NTLA Market Cap & Key Metrics
Intellia Therapeutics, Inc.
$12.28
+$1.02(+9.06%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
3.82M
52W Range
$7.95 - $28.25
Target Price
--
NTLA market cap for Intellia Therapeutics, Inc.. This page lists Intellia Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
NTLA Key Metrics
- EPS growth, 3-year
- +14.80%
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $67.67M | $57.88M | $36.27M | $52.12M | $33.05M |
| EBITDA | -$396.77M | -$508.74M | -$472.22M | -$466.61M | -$253.40M |
| EPS | $-3.81 | $-5.25 | $-5.42 | $-6.16 | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $12.28 | +9.1% | 3.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW